跳至主要内容
临床试验/NCT03330392
NCT03330392已完成不适用

An 8 Week, Randomized, Double-blind, Placebo-controlled Clinical Trial of AGP on Immune Enhancing Effects

Chonbuk National University Hospital2 个研究点 分布在 2 个国家目标入组 80 人开始时间: 2017年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
2
主要终点
Natural killer cell activity

研究概览

简要总结

The researchers investigated the immune enhancing effects of AGP for Korean participants.

详细描述

The aim of the study is to investigate the effects of AGP on immune enhancement based on 8 week, randomized, double-blind, placebo-controlled clinical trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The levels of white blood cells within range 3x10^3/μL~8x10^3/μL
  • have had at least two cold in the last 12 months.

排除标准

  • subjects with BMI<18.5 kg/m^2
  • subjects taking medications such as immune related drug or functional foods
  • history of disease that could interfere with the test products or impede their absorption
  • pregnant or lactating women and heavy smokers.
  • being judged by the responsible physician of the local study center as unfit to participate in the study

结局指标

主要结局

Natural killer cell activity

时间窗: 0 week, 8 week

Changes of NK cell activity were assessed before and after the intervention.

次要结局

  • Interferon-γ (IFN-γ)(0 week, 8 week)
  • Interleukin-1β(0 week, 8 week)
  • Interleukin-6(0 week, 8 week)
  • Interleukin-12 (IL-12)(0 week, 8 week)
  • Tumor necrosis factor-α (TNF-α)(0 week, 8 week)
  • Changes of White blood cell (WBC)(0 week, 8 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Soo-Wan Chae

Principal Investigator, Clinical Trial Center for Functional Foods

Chonbuk National University Hospital

研究点 (2)

Loading locations...

相似试验